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Abstract
Background: Neurological soft signs and neurocognitive impairments have long been considered important features of
schizophrenia. Previous correlational studies have suggested that there is a significant relationship between neurological
soft signs and neurocognitive functions. The purpose of the current study was to examine the underlying relationships
between these two distinct constructs with structural equation modeling (SEM).
Methods: 118 patients with schizophrenia and 160 healthy controls were recruited for the current study. The abridged
version of the Cambridge Neurological Inventory (CNI) and a set of neurocognitive function tests were administered to all
participants. SEM was then conducted independently in these two samples to examine the relationships between
neurological soft signs and neurocognitive functions.
Results: Both the measurement and structural models showed that the models fit well to the data in both patients and
healthy controls. The structural equations also showed that there were modest to moderate associations among
neurological soft signs, executive attention, verbal memory, and visual memory, while the healthy controls showed more
limited associations.
Conclusions: The current findings indicate that motor coordination, sensory integration, and disinhibition contribute to the
latent construct of neurological soft signs, whereas the subset of neurocognitive function tests contribute to the latent
constructs of executive attention, verbal memory, and visual memory in the present sample. Greater evidence of
neurological soft signs is associated with more severe impairment of executive attention and memory functions. Clinical and
theoretical implications of the model findings are discussed.
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Introduction
Neurological soft signs are classically referred to as the minor,
non-localizable, and objective abnormalities that are considered to
reflect disturbances in connections between subcortical and
cortical regions or between cortical regions [1–3]. Typical signs
include impairments in motor coordination, sensory integration,
motor sequencing of complex movements and the corresponding
disinhibition of associated movements that can be elicited
objectively and rated reliably [1,4–7]. Typical soft signs are seen
in the majority of individuals with schizophrenia [8–10]. The
crucial role of neurological soft signs in schizophrenia has been
considered as among the ‘‘target features’’ that encompass the idea
that both genetic and non-genetic processes lead to maldevelop-
ment in neurocognitive systems [11,12].
On the other hand, neurocognitive deficits have also been
consistently demonstrated in schizophrenia [13,14]. Previous
studies suggest that the two distinct constructs of neurological soft
signs and neurocognitive functions are actually capturing similar
underlying deficits in schizophrenia [15–18]. In the seminal paper
and the subsequent update of the studies of neurological signs and
neurocognitive function in schizophrenia, Buchanan and col-
leagues [4,19] and others [20] further suggested that these two
constructs may serve as the endophenotypes for schizophrenia.
However, previous studies of the relationships between
neurological soft signs and neurocognitive performances in
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schizophrenia have been limited by their designs and methodol-
ogies. First, all of the previous studies adopted a correlational
design [15–17,21–23]. Empirical findings suggest that neurological
soft signs and neurocognitive deficits appear to reflect overlapping
neural substrates, e.g., a simple correlational design might have
underestimated the potential relationship between these two
constructs [24]. Although Arango et al. [17] used a combination
of covariate-controlled stepwise regression analyses and linear
discriminant analyses to investigate the neurocognitive perfor-
mances in patients with schizophrenia, they did not specifically test
the latent constructs of neurocognitive functions and neurological
soft signs. Mohr et al. [25] also administered a comprehensive
neurocognitive function battery to a group of patients with first
episode schizophrenia and healthy controls, and adopted a
multivariate profile analysis to examine the corresponding group
differences. They found that neurological soft signs were
correlated with the main clinical features of the illness and showed
a consistent correlation with neurocognitive functioning in
schizophrenia. However, Mohr et al’s study [26] did not test
specifically whether these two constructs, i.e., neurocognitive
functions and neurological soft signs, accounted for each other.
Moreover, the majority of the findings were limited to western
or Caucasian samples. Buchanan and Heinrichs [5], and Gureje
[27] reported that healthy African Americans have an increased
level of soft signs compared with Caucasians, sensory integration
subscale of the Neurological Evaluation Scale (NES) [5] in
particular. Chen and Chan [28] also found that there was a trend
for Chinese individuals with schizophrenia to have lower scores in
the sensory integration subscore of the Cambridge Neurological
Inventory (CNI) [6]. These findings tentatively suggest that among
the subscales in the NES and CNI, sensory integration may be
more vulnerable to ethnic variation. However, it is not clear
whether we can generalize these western-based findings to eastern
and non-Caucasian samples.
Finally, in line with the former argument, most of these studies
have emphasized the relationship between neurological soft signs
and neurocognitive functions in schizophrenia, as very little is
known about the corresponding relationships in healthy or non-
clinical samples. Most recent empirical findings, e.g., Dazzan et al.
[29] indicated that higher rates of neurological soft signs were
associated with a reduction of inferior frontal gyrus, middle and
superior temporal gyrus, and anterior cingulate gyrus in non-
clinical volunteers, indicating that specific brain regions are
actually serving for the neuroanatomical substrates of neurological
soft signs across healthy individuals and schizophrenic patients.
Given that neurological soft signs are also demonstrated in
healthy, non-clinical samples, and non-psychotic relatives of
patients with schizophrenia [2,30–34], and the observable
variations of neurocognitive performances between clinical and
non-clinical samples, e.g., it is worthwhile to extend such an
investigation to non-clinical samples [35].
Taken together, preliminary studies suggest that neurological
soft signs can be considered to be the endophenotype for
schizophrenia. Endophenotype has been considered to be an
internal phenotype that is not obvious to the unaided eyes and can
fill the gap between symptoms and the putative genes that
actualize the elusive disease processes of schizophrenia and other
psychiatric disorders [36]. Most of the previous studies of
endophenotypes have focused primarily on conventional neuro-
cognitive functions such as attention, memory and executive
functions. Very little attention has been paid on the study of
neurological soft signs as the alternate ‘‘neurocognitive’’ endophe-
notype for schizophrenia. Given that the administration of
conventional neurocognitive function tests is relatively time-
consuming, the assessment of a shorter equivalent form of
neurocognitive function may save time for the tight clinical
routines for practitioners. The nature and characteristics of the
neurological soft signs testing suggest that this test can be more
feasible for clinicians to screen for any neurocognitive impairment
in schizophrenia. The administration of neurological soft signs
only takes up about 15 minutes. For instance, the Lurian Fist-
Edge-Palm test [37] of motor function is often used in
neuropsychological assessment as a quick and easy-to-administer
test that is sensitive to schizophrenia [38]. Modifications of this
task and other similar movement involving rhythm and repetitive
action like simpler finger tapping, alternate finger tapping as well
as diadochokinesia have been incorporated as subtests in
standardized tests for frontal-executive functions [39–41]. To be
the potential endophenotypes, the relationship observed in clinical
group should also be extended to a non-clinical group, but in an
attenuated form, i.e., criterion of association of the illness in
population. However, very few studies on neurological soft signs
have been equally attended to the non-clinical samples.
The present study adopted the structured equation modeling
(SEM) strategy to examine the underlying relationships between
neurological soft signs and neurocognitive functions in both
healthy volunteers and patients with schizophrenia. The strength
of the SEM approach is to examine the latent structure of the two
constructs of neurological soft signs and neurocognitive functions
and their corresponding relationships simultaneously (for details,
refer to the methodology section below). In this way, we can
investigate these two constructs at an explanatory level rather than
an exploratory level (as the majority of the previous studies have).
Given the above arguments, we hypothesized that conventional
neurocognitive functions and neurological soft signs serve as the
same level of neural basis of higher cortical functioning. Moreover,
it was also hypothesized that there were similar associations
between neurocognitive measures and neurological soft signs in
both schizophrenia and healthy controls; however, such associa-
tions may be attenuated in healthy controls.
Methods
Participants
The participants included 118 in-patients with schizophrenia
(100 men and 18 women) recruited from Queen Mary Hospital of
Hong Kong, Institute for Mental Health of the Peking University,
and Anding Hospital in Beijing. Part of the findings of the
prevalence rate of neurological soft signs in the Hong Kong
sample (77 patients) has been reported in our previous study
[34,38]. All of the patients met the DSM-IV [42] criteria for
schizophrenia and were outpatients. A consensus diagnosis was
arrived at after two experienced psychiatrists performed face-to-
face interviews using the Structured Clinical Interview for the
DSM-IV. The exclusion criteria included physical illness that
involved the central nervous system, life time substance or alcohol
abuse and clinical evidence of mental retardation, and comorbid
mental illnesses. The mean age and years of education were 40.23
years (SD = 12) and 9.47 years (SD = 3.76), respectively. The mean
length of illness was 16.04 years (SD = 11.91).
Another sample of 160 healthy people (62 men and 98 women)
was recruited from Beijing and Guangzhou, China. They were all
recruited from the sample pool for an assessment of neuropsy-
chological performance. All participants were screened by a brief
mental health status questionnaire by research assistants who were
trained to administer the questionnaire. This questionnaire was
mainly used to capture items whether the healthy volunteers had a
family history of mental illnesses based on a dichotomous response.
Soft Signs and Neurocognition
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The exclusion criteria were the same as the patient group in
addition to having a previous history of mental illnesses. The mean
age and mean number of education of the healthy controls were
25.87 years (SD = 8.76) and 14.68 years (SD = 2.56), respectively.
The mean IQ estimate assessed by the Wechsler Adult Intelligence
Scale – Revised (Chinese version [43], was 117.39 (SD = 18.15).
The IQ of these healthy volunteers was relatively high, possibly
because these participants were recruited mainly from the local
universities of Beijing and Guangzhou. All the patients and healthy
volunteers were Han Chinese. Significant differences were found
between the patient and healthy groups in terms of age, education,
and gender proportion. However, as the main purpose of the study
was not to compare the neurocognitive performances between the
two groups, such differences would not affect our final modeling
results.
Neurocognitive Functions
Executive attention is evaluated with a set of tests specifically
designed to capture the executive component of attention control.
The Sustained Attention to Response Task (SART) [44] is a
computer test during which participants respond with a key press
to the occurrence of a target stimulus (digit) while inhibiting/
withholding the response to the non-target digit ‘‘3’’. This test has
been demonstrated to capture sustained attention and disinhibi-
tion in clinical samples including schizophrenia [45]. The modified
version of the Wisconsin Card Sorting Test (MCST) [46] was used
to assess switching and flexibility. The main difference between
this version and original version of Wisconsin Card Sorting Test
[47] is that the modified version informs the subject about the
change of rule of sorting criteria. The Verbal Fluency Test was
also used to measure executive function. Participants were
instructed to generate as many exemplars of animal names as
possible within 1 minute.
Verbal memory and visual memory were measured by the
Logical Memory Subscale and Visual Reproduction Subscale from
the Chinese version of the Wechsler Memory Scale-Revised [48],
respectively.
Neurological Soft Signs
Neurological soft signs were evaluated with the soft signs
subscales of the CNI [6]. The motor coordination subscale consists
of items assessing rapid motor movements such as finger-thumb
opposition, diadochokinesia, and fist-edge-palm. The sensory
integration subscale consists of items evaluating tactile sensation
such as extinction, left-right discrimination and stereognosis. The
disinhibition subscale consists of items for withholding or
inhibiting associated movements such as head movement while
performing saccadic tracking of objects and corresponding
associated movements (mirror movement) while performing rapid
alternating movements in diadochokinesia. In the original scale,
scoring was made according to standardised anchor points to
indicate ‘‘normal’’ response (scored as 0), ‘‘equivocal response’’
(0.5), ‘‘abnormal’’ response (1) or ‘‘grossly abnormal’’ response (2).
In the present study, item scores were dichotomized into either
‘‘absent’’ (covering normal or equivocal) or ‘‘present’’ (covering
abnormal or grossly abnormal). Interrater reliability on the
subscale scores were calculated for each of the subscales based
on investigators’ ratings on 15 independent cases by three raters.
The intraclass correlation coefficient for the CNI was 0.85 for the
total CNI score. The intraclass correlation coefficients for the
subscales were as follows: motor coordination (0.91), sensory
integration (0.82), and disinhibition (0.9). Chan and Chen [34]
have demonstrated that the CNI is able to discriminate between
patients with schizophrenia and healthy controls in the context of
Chinese setting, using the three subscales of neurological soft signs.
Statistical Analysis
SEM was conducted with the LISREL 8.53 for Windows [49]
used to analyze the current findings. SEM is a statistical technique
for testing and estimating causal relationships using a combination
of statistical data and qualitative causal assumptions. The SEM
consists of two models, namely the measurement model and
structure model [50]. The measurement model shows the relations
between the latent variables and their indicators, whereas the
structure model shows the potential causal dependencies between
endogenous and exogenous variables. In the current study, the
measurement model was based on a four-factor measurement
model consisting of four latent variables, namely the Executive
Functions, Verbal Memory, Visual Memory, and Neurological
Soft Signs. Specifically, the SART Correct Response, Verbal
Fluency, and WCST Category were ascribed to ‘‘Executive
Functions’’; the Logical Memory Immediate Recall and Logical
Memory Delayed Recall were ascribed to ‘‘Verbal Memory’’; and
the Visual Reproduction Immediate Recall and Visual Repro-
duction Delayed Recall were ascribed to ‘‘Visual Memory’’. On
the other hand, the Motor Coordination, Sensory Integration, and
Disinhibition were ascribed to ‘‘Neurological Soft Sign’’. For the
structural model, it shows the relationships between the conven-
tional neurocognitive functions, i.e., Executive Functions, Verbal
Memory, and Visual Memory, and the latent variable of
Neurological Soft Signs (which was contributed by the motor
coordination, sensory integration, and disinhibition).
The validity of the model was tested with chi-square test and fit
indices. Five fit indices have been developed for evaluating how
the model fits the data, namely the Normed Fit Index (NFI), Non-
Normed Fit Index (NNFI), Comparative Fit Index (CFI),
Incremental Fit Index (IFI), and RMSEA (Root Mean Square
Error of Approximation). These indices represent the improve-
ment in fit between the assumed model and the baseline model of
uncorrelatedness between the observed variables. The first four fit
indices values of .90 or above, and RMSEA value of .08 or less
indicated the model adequately fits the data [51,52]. Moreover, in
checking the validity of the model, we conducted the SEM analysis
separately for the patients with schizophrenia and healthy
volunteers.
Procedures
This study was approved by the ethics committees of the
corresponding hospitals and the Institute of Psychology, Chinese
Academy of Sciences, the Institute of Mental Health of Peking
University, and the University of Hong Kong. Informed written
consent was obtained from all participants before the testing
session according to the Declaration of Helsinki. A trained
research assistant administered the tests in a quiet cubicle.
Results
Preliminary Analyses
Means, standard deviation, and zero-order correlation among
the performance of 11 tests of 209 participants are shown in
Table 1. For further analyses, the raw scores of each neurocog-
nitive test of sample were transformed to standardized scores
(mean of 0, SD of 1, range 23 to3).
Testing the Measurement Model
The results showed that the four-factor measurement model fit
the data relatively well. All of the loadings of the observed
Soft Signs and Neurocognition
PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8469
variables on corresponding latent variables were above 0.4 and
statistically significant (p,0.01, see Table 2). Thus, all of the latent
variables appear to have been adequately measured by their
respective observed variables. Furthermore, correlations between
the independent latent variable (Soft Sign) and dependent latent
variable (i.e. Attention/Executive Function, Logical Memory, and
Visual Memory) were all statistically significant (p,0.01, see
Table 3).
Testing the Structure Model
The results showed a good fit of the structure model to the data
in both samples. In the patient group, the model fit well to the
data, x2 (29) = 39.48, p = 0.093, NFI = 0.96, NNFI = 0.98,
CFI = 0.99, IFI = . 099, RMSEA = 0.056. The structural paths
from neurological soft signs to executive attention, verbal memory,
and visual memory were 20.56, 20.47, and 20.54, respectively,
and all statistically significant (p,0.01, see Figure 1).In the control
group, similar fitting was demonstrated, x2 (29) = 47.79, p = 0.
0015, NFI = 0.93, NNFI = 0.95, CFI = 0.97, IFI = 0.97,
RMSEA = 0.064. The structural paths from neurological soft
signs to executive attention, verbal memory, and visual memory
were 20.54, 20.26, and 20.17, respectively, and all statistically
significant (p,0.01, see Figure 2). These results suggest that
neurological soft signs have important negative influence on
executive attention, verbal memory, and visual memory. In other
words, greater evidence of neurological soft signs is associated with
more severe impairment of executive attention and memory
functions.
Discussion
The current findings indicate that, on the one hand, in the
measurement model of the SEM that motor coordination, sensory
integration, and disinhibition subscales contributed to the latent
construct of neurological soft signs, whereas the subset of
neurocognitive function tests contributed to the latent constructs
of executive attention, verbal memory, and visual memory in the
present sample. On the other hand, the structural model showed
Table 1. Means, Standard Deviation, and Zero-Order Correlation among Performance of 10 Tests in Patients with Schizophrenia
and Healthy Volunteers.
Tests M SD 1 2 3 4 5 6 7 8 9 10
Sch Patient Sample (N = 118)
SART Correct Response 165.58 37.57 – .51** 2.42** .38** .34** .49** .49** 2.33** 2.25** 2.02
Verbal Fluency 14.17 6.23 – 2.42** .48** .46** .63** .55** 2.37** 2.41** 2.05
WCST Perseverative Error 14.47 14.91 – 2.43** 2.45** 2.34** 2.35** .33** .22** 2.10
Logical Memory Immediate
Recall
6.28 4.32 – .83** .53** .54** 2.38** 2.38** 2.04
Logical Memory Delayed
Recall
4.20 4.03 – .49** .47** 2.38** 2.31** 2.01
Visual Reproduction
Immediate Recall
15.92 6.99 – .84** 2.44** 2.41** 2.11
Visual Reproduction Delayed
Recall
13.48 7.90 – 2.42** 2.38** .00
Motor Coordination 4.44 2.83 – .61** .41**
Sensory Integration 2.00 1.72 – .34**
Disinhibition 3.30 1.74 –
Healthy Sample (N = 160)
SART Correct Response 196.44 7.24 – .30** 2.48** .33** .32** .31** .32** 2.30** 2.20* 2.22**
Verbal Fluency 21.71 6.10 – 2.31** .31** .29** .41** .43** 2.14 2.24** 2.02
WCST Perseverative Error 1.63 3.01 – 2.32** 2.30** 2.26** 2.28** .20* .20* .13
Logical Memory Immediate
Recall
14.66 4.02 – .88** .26** .31** 2.23** 2.05 2.11
Logical Memory Delayed
Recall
12.82 4.48 – .23** .30** 2.24** 2.07 2.10
Visual Reproduction
Immediate Recall
22.93 2.13 – .76** 2.02 2.20* 2.20*
Visual Reproduction Delayed
Recall
22.66 2.12 – .02 2.22** 2.06
Motor Coordination 1.21 1.62 – .37** .32**
Sensory Integration 1.18 1.50 – .31**
Disinhibition 1.22 1.06 –
Note. * p,.05, ** p,.01.
1: SART correct response; 2: Verbal Fluency; 3: MCST perseverative error; 4: Logical Memory Immediate Recall; 5: Logical Memory Delayed Recall; 6: Visual Reproduction
Immediate Recall; 7: Visual Reproduction Delayed Recall; 8: Motor Coordination; 9: Sensory Integration; 10: Disinhibition.
Cutoff of correlation coefficient at 0.05 level is 0.197 and at 0.01 level is 0.256 for df = 100; cutoff of correlation coefficient at 0.05 level is 0.139 and at 0.01 level is 0.182
for df = 200.
doi:10.1371/journal.pone.0008469.t001
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that there were significant structural pathways from neurological
soft signs to executive attention, verbal memory, and visual
memory. In other words, more evidence of neurological soft signs
is associated with more severe impairments in executive attention
and memory functions.
To a large extent, these findings are consistent with previous
correlational studies, namely that neurological soft signs are
associated with specific neurocognitive deficits rather than a
generalized dysfunction [15,16,22]. Instead of linking different
subscales of neurological soft signs to specific domains of
neurocognitive functions, the main uniqueness of the current
findings is the use of the SEM to translate the composition of the
soft signs categories into a latent construct of neurological soft signs
and to link these signs to specific neurocognitive deficits. As we
argue above, the strength of this approach is to examine these two
constructs (neurological soft signs and neurocognitive functions) at
an explanatory level rather than an exploratory level.
The current findings tend to support the view that neurological
soft signs and neurocognitive tests are two ways of capturing the
same construct, i.e., ultimate brain functioning. Most recent
empirical findings from structural [29,53] and functional imaging
[24,54–56] also suggest that specific brain structural changes
reflect a common neuroanatomical substrate of neurological soft
signs, across patients with schizophrenia and non-clinical subjects.
For example, Schroder et al. [56] found that there were significant
reductions in brain activation in the sensorimotor cortex and
supplementary motor areas in schizophrenia as compared to
healthy controls while they were performing a diadochokinesia like
task (pronation/supination). Chan et al. [24] and Rao et al. [54]
further showed that the involvement of the supplementary motor
area might be the genesis of the Fist-Edge-Palm sign (one of the
motor coordination signs) in healthy volunteers and there was a
reduction of brain activation in the network between right inferior
and right middle prefrontal areas when healthy volunteers were
Table 2. Factor Loadings for the Measurement Model in Patients with Schizophrenia and Healthy Volunteers.
Measure and Variable Sch Patient Sample (N=118) Healthy Sample (N=160)
Untandardized
factor loading SE
Standardized
factor loading p
Untandardized
factor loading SE
Standardized
factor loading p
Attention/Executive Function
SART Correct Response 24.54 3.38 .65 .000 4.77 .61 .66 .000
Verbal Fluency 4.92 .54 .79 .000 3.39 .52 .56 .000
WCST Perseverative Error 28.30 1.39 2.56 .000 21.83 .25 2.61 .000
Logical Memory
Logical Memory Immediate Recall 4.07 .33 .94 .000 3.85 .28 .96 .000
Logical Memory Delayed Recall 3.55 .32 .88 .000 4.12 .32 .92 .000
Visual Memory
Visual Reproduction Immediate Recall 6.60 .51 .94 .000 1.78 .17 .84 .000
Visual Reproduction Delayed Recall 7.03 .60 .89 .000 1.93 .17 .91 .000
Soft Sign
Motor Coordination 2.44 .26 .86 .000 1.10 .17 .68 .000
Sensory Integration 1.25 .16 .73 .000 .84 .15 .56 .000
Disinhibition .75 .17 .43 .000 .51 .10 .48 .000
doi:10.1371/journal.pone.0008469.t002
Table 3. Correlations among Latent Variables for the Measurement Model in Patients with Schizophrenia and Healthy Volunteers.
Latent variable Executive Attention Verbal Memory Visual Memory Neurological Soft Sign
Sch Patient Sample (N = 118)
Executive Attention – .67** .80** 2.56**
Verbal Memory – .60** 2.47**
Visual Memory – 2.54**
Neurological Soft Sign –
Healthy Sample (N = 160)
Executive Attention – .54** .61** 2.54**
Verbal Memory – .34** 2.26**
Visual Memory – 2.17*
Neurological Soft Sign –
Note. * p,.05, ** p,.01.
Cutoff of correlation coefficient at 0.05 level is 0.197 and at 0.01 level is 0.256 for df = 100; cutoff of correlation coefficient at 0.05 level is 0.139 and at 0.01 level is 0.182
for df = 200.
doi:10.1371/journal.pone.0008469.t003
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instructed to perform such a task. The data from the patients and
healthy volunteers provide converging evidence of the current
models.
The regression coefficients between neurological soft signs and
the conventional neurocognitive functions were more significant
and greater in the patient group than the healthy volunteers
group. This is consistent with the a priori hypothesis that similar but
attenuated associations would be found between conventional
neurocognitive functions and neurological soft signs in healthy
volunteers. However, it should be noted that while the
measurement models of these two samples were meaningful, the
p-values for the structural model of schizophrenia and healthy
volunteers are 0.96 and 0.015, respectively. That means the data
in the schizophrenia sample were more stable and stringent in
reflecting the underlying relationships between these constructs
(neurological soft signs and conventional neurocognitive functions)
than those in healthy volunteers. This might be due to the fact that
the prevalence rate of neurological soft signs in healthy volunteers
is much lower than that of schizophrenic patients and most of the
healthy volunteers might not suffer from any deficits of
neurocognitive functions.
Despite the rigorous adoption of SEM, the current study is
limited by several methodological design features. Further work is
warranted to address the concept that neurological soft signs and
neurocognitive functions are measuring the same construct. First,
the patients and healthy controls were not well-matched
demographically. Although the original purpose of the current
study was not to test the group differences, we would like to
comment about the similarity or difference in the patterns of
associations in the neurocognitive performances and neurological
soft signs evidence. Age and IQ may have influenced these
associations. However, IQ is influenced by the illness and thus
might not be controlled, but age and neurological soft signs might
be linked to each other [22,28]. The current findings are limited
by the lack of psychological assessment of IQ in the schizophrenia
sample, and therefore, the impossibility of testing for differences in
IQ between clinical and non-clinical samples. Nevertheless, a
similar but attenuated pattern of associations between neurocog-
nitive functions and neurological soft signs was also demonstrated
in healthy controls. Further study with a demographically matched
control group to demonstrate a clearer association between these
two supposedly similar constructs could address this concern.
Second, the patient sample was biased to chronic cases with
relatively long lengths of illness and relatively large medication
exposures. It is not clear whether the relationships found in the
chronic cases may be generalized to first-onset medication naı¨ve
patients. However, previous correlational studies on medication
naı¨ve patients suggest that there is quite a robust relationship
between neurological soft signs and neurocognitive impairments
and medication has little effect on these relationships ([5,19] for
review). Also, both chronic and first-episode medication treated
cases suffer similar neurocognitive impairments but the medication
naı¨ve cases demonstrate a lesser extent of impairments [57,58].
Third, the study adopted the subscales of CNI for the evaluation
of neurological soft signs, which is different from the Neurological
Evaluation Scale (NES) [5] often used in previous studies. The two
Figure 1. The structure model of the influence of Soft Sign on cognitive function in patients with schizophrenia. x2 (29) = 39.48,
p = 0.093, NFI = 0.96, NNFI = 0.98, CFI = 0.99, IFI = .99, RMSEA= 0.056. Note. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0008469.g001
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scales share commonalities in their subscales such as the inclusion of
items from the sensory integration and motor coordination.
However, the CNI differs from the NES in that it incorporates the
complex sequencing task items into its motor coordination subscale
instead of classifying it as an independent subscale of complex motor
sequencing, whereas the NES categorizes some of the signs of CNI
into ‘‘other signs’’. On the other hand, it includes items that capture
the ability to inhibit involuntary and associated movements such as
head movement while performing a saccadic task and mirror
(associated) movements observed in the un-tested hand. Once again,
it is not sure whether similar relationship could be generalized to a
different classification of neurological soft signs in schizophrenia.
Nevertheless, studies adopting either the CNI [6,22,28,34,38,45] or
NES [4,7,15,17,19] have shown impressive sensitivity and discrim-
inating power as a comprehensive neurological soft signs battery, and
thus, suggest a valid classification of either approach. More
importantly, the same structural and measurement models derived
from the assessment of both patients and healthy volunteers provide
strong support for the validity of the current observations.
Finally, the current findings were limited to Han Chinese.
Given the potential ethnicity effect on the prevalence rate of
neurological soft signs in either healthy volunteers or schizophren-
ic patients, it is not clear such findings can be generalized to the
western-based samples, which are the main trend of findings
published in the current literature.
Notwithstanding these caveats, the current findings provide one of
the very few preliminary supports for the claim that neurological soft
signs and conventional neurocognitive functions may measure at the
same level of brain functions. These findings may add knowledge to
the understanding of the neural basis of these apparently distinct
constructs is actually capturing the same or similar neural basis of
higher cortical functioning in schizophrenia. The significant
association of these two constructs, particularly for those neurocog-
nitive functions regarding as endophenotypes such as verbal memory
and executive functions, may imply that neurological soft signs may
also serve as the potential cognitive endophenotypes for schizophre-
nia [4,19,20]. The clinical implication could l be straightforward, i.e.
administration of neurological soft signs is simpler and time-saving
for the already tight daily clinical routines and the rating of these
signs are portable and user-friendly as an alternative to conventional
neurocognitive function assessment for schizophrenia or related
disorders research in the future.
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